ASHG

Day 3 at ASHG 2015: Real-life application of genetic variations

(Editor’s note: Missed the earlier ASHG recaps? Find them here! Day One Day Two) In yesterday’s blog, I talked about genetic variability and some concerns about its usefulness. So today, I attended a late evening session, “Clinical Impact of Genetic Variation,” to learn more about how these findings are being used for clinical purposes. The session was led by… Read article →


SingleCell_4Bubbles_700x233

October Webinar Feature: Single cell analysis

Do you wonder what you might find if you narrowed your genomic and transcriptomic analyses down to the single-cell level? If you suppressed the noise from ten thousand other cells, what might an individual cell have to say? Single-cell analysis is a burgeoning area of interest, spurred by advances in sequencing technology. Down to the… Read article →


S_4696_LS_iSt_34145126_s (1)s

Extending miRQC – delving deeper into miRNA platform performance

Recently, QIAGEN set out to investigate the performance of its market-leading miRNA testing platform. A key study released in 2014, the microRNA Quality Control Assessment (miRQC), examined the performance of a number of miRNA quantification systems, including the QIAGEN miScript System. In that study, QIAGEN performed quite well, showing high levels of reproducibility, accuracy and… Read article →



ASHG

Precision Medicine Initiative: recruiting a million people to improve health

ASHG 2015 began yesterday with two great sessions. In the first, ASHG president Dr. Neil Risch reflected on the history of the organization and ASHG’s evolution over the years. In the second session, the Presidential Symposium on “Genetic Epidemiology at Scale: High Throughput Genomics Linked to Large Scale EHR systems,” Dr. Francis Collins talked about the precision… Read article →